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Abstract
Background: Mechanical complications represent an important cause of mortality in myocardial 
infarction (MI) patients. This is a nationwide study performed to evaluate possible changes in epidemi-
ology or prognosis of these complications with current available strategies.
Methods: Information was obtained from the minimum basis data set of the Spanish National Health 
System, including all hospitalizations for acute myocardial infarction (AMI) from 2010 to 2015. Risk-
-standardized in-hospital mortality ratio was calculated using multilevel risk adjustment models.  
Results: A total of 241,760 AMI episodes were analyzed, MI mechanical complications were observed 
in 842 patients: cardiac tamponade in 587, ventricular septal rupture in 126, and mitral regurgitation 
due to papillary muscle or chordae tendineae rupture in 155 (there was more than one complication in 
21 patients). In-hospital mortality was 59.5%. On multivariate adjustment, variables with significant 
impact on in-hospital mortality were: age (OR 1.06; 95% CI 1.04–1.07; p < 0.001), ST-segment eleva-
tion AMI (OR 2.91; 95% CI 1.88–4.5; p < 0.001), cardiogenic shock (OR 2.35; 95% CI 1.66–3.32;  
p < 0.001), cardio-respiratory failure (OR 3.48; 95% CI 2.37–5.09; p < 0.001), and chronic obstructive 
pulmonary disease (OR 1.85; 95% CI 1.07–3.20; p < 0.001). No significant trends in risk-adjusted 
in-hospital mortality were detected (IRR 0.997; p = 0.109). Cardiac intensive care unit availability 
and more experience with mechanical complications management were associated with lower adjusted 
mortality rates (56.7 ± 5.8 vs. 60.1 ± 4.5; and 57 ± 6.1 vs. 59.9 ± 5.6, respectively; p < 0.001).
Conclusions: Mechanical complications occur in 3.5 per thousand AMI, with no significant trends to 
better survival over the past few years. Advanced age, cardiogenic shock and cardio-respiratory failure 
are the most important risk factors for in-hospital mortality. Higher experience and specialized cardiac 
intensive care units are associated with better outcomes. (Cardiol J 2021; 28, 4: 589–597)
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Introduction
Myocardial infarction-related mechanical 
complications (MI-MC) are uncommon but are 
frequently associated with severe morbidity and 
mortality. Presentation can vary from sudden car-
diac death, typically related to pulseless electrical 
activity due to tamponade in free wall rupture, to 
asymptomatic tachycardia, with a new low-sternal 
murmur in some patients. 
Data from different studies suggest that rep-
erfusion therapy reduces the incidence of MI-MC 
when successful and performed in a timely manner 
[1, 2], but MI-MC still carry a very poor prognosis, 
despite important advancements in mechanical 
circulatory support [3–7]. The dismal outcomes 
of conservative therapy [8], leave surgical correc-
tion as a practically inevitable option with results 
depending on the clinical scenario, experience and 
appropriate timing [8–11]. Percutaneous closure of 
septal defects is a possible alternative to surgery, 
but are usually reserved for patients considered too 
ill to be operated on and with experience limited 
to a small number of centers and operators [12].
The past few years have witnessed a con-
siderable growth of new imaging modalities and 
adjunctive therapies for the pre and postoperative 
support of MI-MC [3, 5, 6, 13–15]. However, most 
studies are limited to single-center experiences 
and by relatively small sample sizes. In addition, 
hospital characteristics may have an impact in the 
outcomes of patients with MI [16]. Accordingly, we 
performed a large nationwide retrospective study 
to analyze contemporary epidemiology of MI-MC, 
specifically examining recent trends in prevalence 
and to provide new insight into the impact of cur-
rently available supportive and corrective treat-
ments on in-hospital mortality.
Methods
Data source, population and design
The present study is a retrospective longi-
tudinal study using information provided by the 
minimum basis data set (MBDS) of the Spanish 
National Health System (SNHS). The MBDS is 
an administrative, anonymized database, with 
no information available linking variables to in-
dividual patients. Thus, no specific institutional 
review board authorization or patient informed 
consent documents were necessary [17]. All epi-
sodes with a principal discharge diagnosis of acute 
myocardial infarction (AMI) from January 2010 to 
December 2015 were included. The diagnosis of 
AMI was identified by international classification 
of diseases-9th Revision Clinical modification (ICD- 
-9-CM) codes 410.*1 (410.71 for non-ST elevation 
AMI-NSTEMI-), MI-MC were identified by ICD- 
-9-CM secondary codes 423.3 (cardiac tamponade), 
429.71 (ventricular septal defect, acquired), 429.6 
(rupture of papillary muscle), and 429.5 (rupture of 
chordae tendineae). Cardiac tamponade associated 
with cardiac surgery (codes 996.03, 996.70-79) or 
coronary interventions (998.2) were excluded.
Patients discharged alive at home within 1 day 
after admission, or with missing important demo-
graphics or principal diagnoses were excluded. To 
avoid duplications, transfers to other centers were 
only excluded if we were unable to identify the 
destination hospital. Secondary diagnoses were 
included in groups of risk factors as described by 
Pope et al. [18], updated each year by the Agency 
for Health Research and Quality. The quality of this 
MBDS for the study of acute coronary syndromes 
has been previously validated [19].
Hospital characteristics
Hospitals were qualified as having cardiac 
intensive care units (cICU) if they had: 1) a compre-
hensive critically-ill patient management capabil-
ity, including those requiring invasive mechanical 
ventilation, and 2) administrative adscription of the 
cICU to the cardiology department. 
Statistical analysis
Continuous variables were expressed as 
a mean (standard deviation) and categorical vari-
ables were expressed as numbers and rates. The 
Student t-test was used to compare two categories 
and ANOVA corrected by the Bonferroni test to 
compare three or more. Categorical variables were 
compared by the c2 test or Fisher’s exact test.
Since the probability of a patient dying is, in-
deed, a combination of their individual risk factors 
(case mix) and the quality of care provided (perfor-
mance), the risk-standardized in-hospital mortality 
ratio (RSMR) was defined as the ratio between 
predicted and expected mortality, multiplied by the 
crude rate of mortality. RSMR was calculated using 
multilevel logistic regression models developed 
by the Medicare and Medicaid Service for risk 
adjustment, adapted to the structure of the MBDS 
database. Hospitals were modelled as random in-
tercept considering both inter-hospital variability 
and clinical and demographic variables [20–22]. 
For the adjustment model, we considered only 
comorbidities with an odds ratio (OR) > 1.0. The 
type of AMI (non-ST-segment elevation myocardial 
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infarction [NSTEMI] vs. ST-segment elevation 
myocardial infarction [STEMI]) was included in 
the adjustment models. All factors included in the 
final models and their coefficients were calculated 
from the present data. Levels of significance for 
selecting and eliminating risk factors were p < 0.05 
and p ≥ 0.10, respectively.
Calibration of models was assessed by calculat-
ing risk terciles of the in-hospital mortality observed 
and expected obtained by the logistic multilevel 
model. In order to evaluate the goodness of fit, 
a significant decrease in the statistical likelihood 
ratio test compared to the null model was tested. 
Discrimination was assessed by calculating the 
receiver operating characteristics curves and their 
corresponding area under the curve (AUROC).
Temporal trends for in-hospital mortality dur-
ing the observed period were modelled using the 
Poisson regression analysis with year as the only 
independent variable. Incidence rate ratios (IRR) 
and their 95% confidence intervals (95% CI) were 
calculated. All statistical tests were two-sided. 
and the level of significance for p-values was set 
at 0.05. Statistical analysis was performed using 
STATA 13 and SPSS 21.0.
To discriminate between high and low volume 
centres a K means clustering algorithm was used, 
excluding hospitals with < 1 cases of MC admis-
sions in the study period. The mathematical model 
was developed with two-thirds of the dataset and 
validated with the remaining one third.
Results
Prevalence of MI-MC
A total 277,717 episodes of MI were identified 
in the MBDS during the study period (2010–2015). 
Figure 1 depicts the study flow-chart. A total of 
13% of AMI episodes were excluded, the major-
ity of which (10.6%) for being discharged to other 
unidentified hospitals (Suppl. Table 1). From the 
241,760 AMI selected for analysis, MI-MC were 
present in 842 patients (3.5 per thousand), and 
25 patients had more than one MI-MC, resulting in 
a total number of mechanical complications of 863. 
Cardiac tamponade unrelated to cardiac procedures 
was present in 67.4% of MI-MC cases (n = 863). A ven- 
tricular septal defect was detected in 14.6% and 
mitral regurgitation in 17.9% (rupture of papillary 
muscle in 9.6% and rupture of chordae tendineae in 
8.3%). MI-MC incidence rate was higher in STEMI 
than NSTEMI (4.8 vs. 1.5 per thousand; p = 0.002). 
There was a statistically significant trend to an 
increase of MI-MC throughout 2010–2015 (3.1 per 
Figure 1. Flow chart of study population; SNHS — Spanish National Health System; AMI — acute myocardial 
infarction; STEMI — ST-segment elevation myocardial infarction; NSTEMI — non-ST-segment elevation myocar-
dial infarction; MI-MC — myocardial infarction related mechanical complication; VSR — ventricular septal repture; 
PM-CTR — papillary muscle or chordae tendinae rupture; CT — cardiac tamponade.





VSR: 118 (0.08%) CT: 484 (0.33%)PM-CTR: 124 (0.08%) VSR: 8 (0.01%) CT: 103 (0.11%)PM-CTR: 31 (0.03%)
Without MI-MC: 96,484With MI-MC: 705 (0.48%) With MI-MC: 142 (0.15%)
NSTEMI: 96,626
Age > 35 years old
Transfers to other hospital: 29,463
Discharge to nursing home or against medical advice: 3,423
Unknown destination at discharge: 517
Discharge home £ 1 day: 2,554
Exclusions
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Figure 2. Trends in rates of mechanical complications in ST-segment elevation myocardial infarction (STEMI) and 






























































thousand AMI vs. 4.0 per thousand AMI; IRR 1.10; 
95% CI 1.07–1.13; p < 0.001) with higher rates be-
tween 2013–2015 related with a higher incidence of 
MC in STEMI (Fig. 2). The trend towards MI-MC 
increase was due to cardiac tamponade (IRR 1.1, 
95% CI 1.04–1.14; p < 0.001), without significant 
changes in the other groups.
Differences between AMI patients with or 
without MI-MC are displayed in Table 1. MI-MC 
patients were older (72.4 ± 11 vs. 68.6 ± 14; 
p < 0.001), with a higher prevalence of female sex 
(36.7% vs. 30.3%; p < 0.001), and higher rates 
of cardiac failure, cardiogenic shock or cardio-
respiratory failure and renal failure. 
Risk factors associated with any MI-MC were 
older age, female sex, presentation with STEMI 
instead of NSTEMI, presence of valvular heart 
disease or chronic pulmonary disease and cardio-
genic shock (Suppl. Table 2). The clinical charac-
teristics associated with cardiac tamponade were: 
older age, presentation with STEMI instead of 
NSTEMI and cardiogenic shock (Suppl. Table 3). 
Risk factors for ventricular septal rupture (VSR) 
were: female sex (OR 1.86; 95% CI 1.29–2.67; 
p < 0.001), prior MI (OR 1.63; 95% CI 1.12–2.36; 
p = 0.01), history of congestive heart failure (OR 
2.23; 95% CI 1.53–3.26; p < 0.001), and presenta-
tion with STEMI (OR 6.29; 95%CI 3.03–13.07; 
p < 0.001) and cardiogenic shock (HR 9.44; 95% CI 
6.34–14.05; p < 0.001; Suppl. Table 4). Patients 
with papillary muscle or chordae tendinae rupture 
more frequently had a valvular heart disease, 
presentation with STEMI and cardiogenic shock 
(Suppl. Table 5).
Management of MI-MC
A percutaneous coronary intervention (PCI) was 
performed in 55.7% of the patients with AMI-MC, 
a significantly lower rate compared with AMI 
without MI-MC (59.7%; p = 0.009). However, coro-
nary artery bypass graft surgery (CABG) proce-
dures were more frequent in MI-MC (11.3 vs. 1.8; 
p < 0.001). Along the study period, there was 
a higher trend to use of PCI (IRR 1.12; 95% CI 
1.08–1.17; p < 0.001) and CABG (IRR 1.16; 95% CI 
1.06–1.28; p = 0.002), but no significant changes in 
trends for mitral valve replacement or other major 
cardiac surgery (IRR 0.99; p = 0.13 and IRR 0.99; 
p = 0.05; respectively; Suppl. Fig. 1).
In-hospital outcomes
In-hospital crude mortality rate in MI-MC pa-
tients was 59.5%, while mortality in patients with-
out MI-MC was 9.6% (p < 0.001). The in-hospital 
mortality was 59.1% for cardiac tamponade (344 
episodes), 66.7% for VSR (84 episodes), and 58.1% 
for papillary muscle/chordae rupture (90 episodes: 
63.9% for papillary muscle rupture and 51.4% for 
rupture of chordae tendineae). The mortality was 
81% when there were two MI-MC in the same AMI 
episode (17 episodes). There were no significant 
changes on in-hospital crude mortality rates during 
the 2010–2015 period (IRR 0.99; p = 0.7). 
Table 2 shows the differences in risk factors 
between each MI-MC. Congestive heart failure, 
cardio-respiratory failure and shock, and renal 
failure were more frequent in VSR and mitral 
regurgitation-related complications, compared to 
the cardiac tamponade scenario. NSTEMI was rela-
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tively more frequent in the subgroup with rupture 
of papillary muscle or chordae tendineae.
In the multilevel risk adjustment model, sev-
eral variables were independently associated with 
in-hospital mortality for AMI, including age, diabe-
tes mellitus, cerebrovascular disease and STEMI 
presentation (Suppl. Table 6). Presentation of any 
MI-MC was also a strong predictor of in-hospital 
mortality (OR 9.16; 95% CI 7.65–10.99; p < 0.001). 
Applying the AMI model to the population with MI-
-MC only four variables had a significant effect: age 
(OR 1.06; 95% CI 1.04–1.07; p < 0.001), STEMI 
instead of NSTEMI (OR 2.90; 95% CI 1.87–4.50; 
p < 0.001), cardiogenic shock (OR 2.34; 95% CI 
1.66–3.31; p < 0.001), and cardio-respiratory 
failure (OR 3.48; 95% CI 2.4–5.01; p < 0.001) 
(Table 3). This model showed a fair discriminative 
ability (AUROC 0.78; 95% CI 0.75–0.80) and good 
calibration (p < 0.001). PCI and cardiac surgery 
were independent risk-protective procedures for 
in-hospital mortality in MI-MC (OR 0.37; 95% 
CI 0.27–0.50; p < 0.001 and OR 0.43; 95% CI 
0.30–0.62; p < 0.001, respectively).
In-hospital mortality risk-adjustment models 
for each MI-MC showed significant differences in 
risk factors and their weight (Table 4). However, 
in all of them, cardiogenic shock and/or cardio-
respiratory failure were strong predictors of in-
hospital mortality. Age was an independent risk 
factor only in VSR.
Risk-standardized in-hospital mortality ratio 
for MI-MC patients estimated with this model was 
Table 1. Differences between acute myocardial infarction (MI) patients with and without mechanical 
complications (MC).
Variables MI without MC  
(n = 240,918)
MI with MC  
(n = 842)
P
Age [years] 68.6 ± 14.0 72.4 ± 11.1 < 0.001
Female sex 30.3% 36.7% < 0.001
Cardiovascular risk factors:
Smoking (ICD-9-CM code: V15.82) 40.1% 16.9% < 0.001
Hypertension (CC 95) 49.2% 43.6% < 0.001
Dyslipidemia (CC 25) 15.0% 9.5% < 0.001
Diabetes mellitus (CC 17-19. 123) 32.4% 23.0% < 0.001
Cardiovascular disease:
Peripheral artery disease* 7.2% 8.7% 0.135
Prior myocardial infarction (ICD-9-CM code: 410.01 y 410.11) 44.8% 29.5% < 0.001
History of PCI (ICD-9-CM code: V45.82 y 996.72) 12.0% 7.6% < 0.001
Congestive heart failure (CC 85) 22.6% 34.4% < 0.001
Valvular heart disease (CC 106-108) 7.1% 8.2% 0.251
Comorbidity:
Renal failure (CC 135-140) 15.8% 27.0% < 0.001
Chronic obstructive pulmonary disease (CC 111)  7.5% 9.7% 0.015
Metastatic cancer, acute leukemia and other severe cancers (CC 8-9) 1.2% 0.6% 0.118
Acute MI presentation:
STEMI (410.x1 except 410.71) 60.1% 83.7% < 0.001
Cardiogenic shock (ICD-9-CM code: 785.51) 4.5% 35.2% < 0.001
Cardio-respiratory failure and shock* (CC 84 except 785.51) 9.1% 29.0% < 0.001
Pneumonia (CC 114-116) 2.3% 4.6% < 0.001
Percutaneous coronary intervention 57.9% 55.7% 0.009
Coronary artery bypass graft surgery 1.8% 11.3% < 0.001
PCI — percutaneous coronary intervention; STEMI — ST-segment elevation myocardial infarction; CC — condition categories (Pope et al. [18])
*Peripheral artery disease (ICD-9-CM codes: 040.0. 440.0. 440.1. 440.20. 440.21. 440.22. 440.23. 440.24. 440.29. 440.30. 440.31. 440.32. 440.4. 
441.00. 441.01. 441.01. 441.02. 441.03. 441.1. 441.2. 441.3. 441.4. 441.5. 441.6. 441.7. 441.9. 442.0. 442.1. 442.2. 442.3. 442.81. 442.82. 442.83. 
442.84. 442.89. 442.9. 443.1. 443.21. 443.22. 443.23. 443.24. 443.29. 443.81. 443.82. 443.89. 443.9. 444.01. 444.09. 444.1. 444.21. 444.21. 
444.22. 444.81. 444.89. 444.9. 445.01. 445.02. 445.81. 445.89. 447.1. 447.2. 447.3. 447.5.  447.6. 447.70. 447.71. 447.72. 447.73. 447.8. 447.9. 
448.0. 557.0. 557.1. 557.9. 593.81. 785.4)
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58.5% for the whole period 2010–2015, without 
significant changes along the studied period (IRR 
0.997; 95% CI 0.993–1; p = 0.10), while RSMR 
trend for MI without MC showed a steady decrease 
(IRR 0.97; 95% CI 0.96–0.98; p < 0.001; Suppl. 
Fig. 2).
Hospital characteristics and impact  
of availability of cICU
The availability of cICU was associated with 
a lower RSMR (56.5 ± 5.7 hospitals with cICU 
vs. 60.2 ± 5.7 without cICU; p < 0.001; OR 0.60; 
95% CI 0.42–0.87; p = 0.007). An association was 
also found between higher experience in MI-MC 
management (11 or more MC during the study 
period) and lower RSMR (57 ± 6.1 vs. 59.9 ± 5.6; 
p < 0.001).
Discussion
The present study represents one of the larg-
est series of patients with MI-MC. The main find-
ings are: 1) the rates of MI-MC are 3.5 per thousand 
MI, similar to other contemporary series and with 
a small increase in the past few years [23, 24]; 
2) the most frequent MI-MC is cardiac tamponade 
(2.4 per thousand), most likely related to free wall 
rupture, as PCI or CABG-related tamponade were 
excluded from this analysis, followed by mitral 
valve complications and VSR; 3) despite applica-
tion of current adjunctive and corrective therapies, 
in-hospital mortality rates are still very high, vary-
ing from 59.1% and 58.1% in cardiac tamponade 
and papillary muscle/chordae tendineae rupture, 
respectively, to 63.9% in VSR; 4) age, heart failure 
Table 2. Differences among types of mechanical complications, baseline characteristics and comorbidities.









N 582 126 155 21
Age [years] 71.78 ± 10.9 73.8 ± 10.0 73.0 ± 12.3 75.5 ± 12.9*
Female sex 35.2% 46.0% 34.19% 33.3%
Cardiovascular risk factors:
Smoking (ICD-9-CM code: V15.82) 10.1% 4.8% 10.3% 4.8%
Hypertension (CC 95) 44.5% 43.7% 38.1%* 28.6%
Dyslipidemia (CC 25) 30.2% 27.0% 27.7%* 23.8%
Diabetes mellitus (CC 17-19. 123) 24.4% 24.6% 16.8%* 23.8%
Cardiovascular disease:
Peripheral artery disease 9.1% 9.5% 5.8% 4.8%
Prior myocardial infarction  
(ICD-9-CM code: 410.01 y 410.11)
34.5% 49.2%* 14.2%* 33.35
History of PCI (ICD-9-CM code: V45.82 y 996.72) 7.6% 7.9% 6.5%* 0.0%
Congestive heart failure (CC 85) 26.3%* 47.6%* 54.8%* 38.1%
Comorbidity:
Renal failure (CC 135-140) 22.2%* 41.3% 32.3%* 19.1%
Chronic obstructive pulmonary disease (CC 111) 10.5% 10.3% 5.8% 4.8%
Metastatic cancer, acute leukemia and other  
severe cancers (CC 8-9)
0.7% 0.0% 0.7% 0.0%
Dementia or other specified brain disorders  
(CC 51-53)  
2.6% 4.8% 4.5% 4.8%
Trauma, other injuries (CC 166-168. 170-174)  16.5%* 15.1% 6.5% 4.8%
Acute myocardial infarction presentation
NSTEMI (410.71) 17.7% 6.4%* 20.0%* 0.0%*
Cardiogenic shock (ICD-9-CM code: 785.51) 30.2%* 47.6%* 45.2%* 47.6%
Cardio-respiratory failure (CC 84 except 785.51) 28.7% 24.65 35.5%* 42.9%
Pneumonia (CC 114-116) 5.0% 2.4% 4.5% 0.0%
*p < 0.01; MC — mechanical complications; PCI — percutaneous coronary intervention; NSTEMI — non ST-segment elevation myocardial 
infarction; CC — condition categories (Pope et al. [18])
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and cardiogenic shock are strong predictors of in-
hospital mortality; 5) hospitals with specialized 
cardiac critical care units, managed by Cardiology 
Departments, present better results.
The current results differ from a large database 
in the United States, in which MI-MC occurred in 
0.27% of all STEMI patients, and 0.06% in NSTEMI, 
with a lower presence of free-wall rupture, (0.01%, 
compared to 0.21% for ventricular septal defects 
and 0.05% for papillary muscle rupture) [24]. Im-
portantly, the study by Elbadawi et al. [24] used the 
ICD-9 code 553.9 for “free-wall rupture”. This code 
matches with “hernia of unspecified site without 
mention of obstruction or gangrene” and is not 
used in the Spanish MBDS for the description of 
post-MI free-wall rupture. Despite the important 
limitation of including tamponade as a clinical cor-
relate of free-wall rupture, the present estimations 
are more in accordance with our clinical experience 
and other reports [1]. However, the two databases 
provide similar results regarding a relatively stable 
prevalence of MI-MC over the past few years and 
the steady high mortality rates.
Therapeutic options for MI-MC apparently do 
not impact survival, despite advances in peripheral 
mechanical circulatory support and various corrective 
techniques [1, 11, 15, 24]. Surgical techniques for 
the repair of the infarcted tissue of ventricular septal 
defects have been stable over the past decades and 
the relatively low prevalence has limited surgeons’ 
experience to a small number of cases per year, 
even in high-volume centres. Percutaneous closure 
of ventricular septal defects appears feasible, but 
greatly challenged by the anatomical complexity of 
the defects and carries a high risk of recurrences due 
to the friable borders of the infarcted septum [12].
Table 3. Multivariate analysis for in-hospital mortality of patients with acute myocardial infarction with 
mechanical complications.
Risk factor Odds ratio 95% CI P
Age (18–44 years):
45–54 1.57 0.19–3.81 0.829
55–64 1.04 0.17–3.05 0.657
65–74 1.77 0.25–4.25 0.964
75–84 3.68 0.59–9.92 0.219
85–94 8.19 1.24–24.54 0.025
≥ 95 19.94 0.00–0.00 0.981
STEMI (410.*1 except 410.71) 2.91 1.94–4.49 < 0.001
Cardiogenic shock (ICD-9-CM code: 785.51) 2.35 1.83–3.62 < 0.001
Cardio-respiratory failure (%) (CC 84 except 785.51) 3.48 2.10–4.37 < 0.001
Chronic obstructive pulmonary disease (CC 111) 1.85 1.07–3.19 0.027
Percutaneous coronary intervention* 0.37 0.27–0.50 < 0.001
Other major surgery* 0.43 0.30–0.62 < 0.001
*Effect of the interventions on the risk-adjustment basal model; CI — confidence interval; NSTEMI — non-ST-segment elevation myocardial 
infarction; CC — condition categories (Pope et al. [18])
Table 4. Variables independently associated with in-hospital, all-cause mortality adjusted by risk in  
a multilevel logistic regression model for different mechanical complications.
Risk factor CT VSR PM/CT rupture
OR 95% CI OR 95% CI OR 95% CI
STEMI (410.*1, except 410.71) 2.43 1.52–4.00
Cardiogenic shock (ICD-9-CM code: 785.51) 9.97 3.35–29.69 4.68 1.89–11.62
Cardio-respiratory failure and shock (CC 84 except 785.51) 3.09 2.01–4.73 3.35 1.38–8.11
Acute myocardial infarction (CC 86) 2.18 1.18–4.05
CT — cardiac tamponade; VSR — ventricular septal rupture; PM/CT — papillary muscle or chordae tendineae rupture; OR — odds ratio; CI — 
confidence interval; STEMI — ST-elevation myocardial infarction; CC — condition category (Pope et al. [18])
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Unfortunately, the possible contribution of 
mechanical support manoeuvres, especially veno-
arterial extracorporeal membrane oxygenation 
(VA-ECMO) or percutaneous VSR repair could 
not be addressed in this study due to difficulties 
with non-uniform codification within the MDBS. 
Advanced age, cardio-respiratory failure and cardio-
genic shock were the main independent predictors 
of total mortality in this study. 
Current guidelines recommend centralizing 
the care of patients with cardiogenic shock in 
highly specialized centres [25], since this approach 
has been consistently associated with better out-
comes in this clinical setting [26]. In this study, 
the availability of an cICU and higher experience 
in the management of these patients were both 
associated with higher survival rates, probably 
reflecting the effect of specialized training and 
expertise in the diagnosis and management of MI 
with complications.
Limitations of the study
This study has a number of limitations that 
have to be considered. First, this is a retrospec-
tive analysis. The use of administrative records 
to estimate outcomes has been widely applied 
to research on health service outcomes [27, 28]. 
Second, 10.6% of episodes were not included in 
the study population for being discharged to other 
acute general hospitals. This elimination process 
was necessary to avoid duplications and because in-
hospital outcomes for these patients were not avail-
able. Third, as mentioned, the diagnosis of free wall 
rupture is not clearly specified in ICD-9 codes and 
therefore cardiac tamponade was used as probably 
infarct-related, after excluding those clearly caused 
by invasive procedures. We believe this variable 
served as a correlate of free-wall rupture, but it is 
not a substitute for autopsy or surgically-proven 
rupture, because another cause could be episteno-
cardic or inflammatory pericarditis. However, the 
mortality rates observed in this study (59.1%) are 
not typical of post-infarction pericarditis. In addi-
tion, a certain degree of misdiagnosis could not 
be excluded, as some patients may present with 
sudden death or electromechanical dissociation 
without imaging or autopsy confirmation of cardiac 
tamponade. With respect to the adjustment models, 
there are confounding factors that are impossible 
to identify, but may have a significant impact. The 
presence of cardio-respiratory failure and shock is 
under-estimated in MBDS. The secondary diagno-
ses employed as risk-adjustment variables may cor-
respond to conditions that are present on admission 
or to complications that may occasionally reflect in-
adequate treatment. Nevertheless, the models used 
in this study compare favourably against models 
published elsewhere regarding predictive capacity 
[29]. Finally, limited information on detailed clini-
cal characteristics such as time between beginning 
of symptoms and primary PCI and between culprit 
vessel revascularization and diagnosis of MI-MC 
precluded more detailed analysis of predictors of 
different complications and outcomes.
Future perspectives
Much work needs to be done in reducing mor-
tality in this complex scenario. There is an urgent 
need to explore the role of different circulatory sup-
port modalities, especially in VSR, and the impact 
of emerging interventional techniques, ideally in 
a prospective, randomized design. 
Conclusions
Myocardial infarction-mechanical complica-
tions occur in 3.5 per thousand MIs and are more 
typically related to STEMI, with a slight increase 
in prevalence over the past years. Cardiac tampon-
ade is the most frequent presentation, accounting 
for 69% of all MI-MC. These conditions still carry 
a very high mortality risk, that has not been 
changing over the past few years. Advanced age 
and cardiogenic shock are the most important 
risk factors for in-hospital mortality. Availabil-
ity of highly specialised and experienced CICU 
favourably impact in-hospital outcomes in this 
complex scenario.
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